These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22232)

  • 1. Genetic characteristics of clones derived from measles virus strain L-16.
    Shteinberg LS; Gordienko NM
    Acta Virol; 1977 Sep; 21(5):383-90. PubMed ID: 22232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in some genetic markers of measles virus strain L-16 in the course of passaging in various cell cultures.
    Gordienko NM; Yakovleva GS; Andzhaparidze OG
    Acta Virol; 1973 Jul; 17(4):366. PubMed ID: 4148223
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity with respect to s and T50 markers of various measles virus populations, variants of the Edmonston vaccine strain.
    Khozinsky VI; Seibil VB; Panteleyeva NS; Shapovalova SM
    Acta Virol; 1967 Nov; 11(6):506-10. PubMed ID: 4383885
    [No Abstract]   [Full Text] [Related]  

  • 5. Attenuation and characterisation of Edmonston-Zagreb measles virus.
    Ikić D; Juzbasić M; Beck M; Hrabar A; Cimbur-Schreiber T
    Ann Immunol Hung; 1972; 16(0):175-81. PubMed ID: 4679646
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of temperature-sensitive mutants of measles virus.
    Morikawa Y; Yoshikawa Y; Sato TA; Yamanouchi K
    Kitasato Arch Exp Med; 1991 Apr; 64(1):15-30. PubMed ID: 1724677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on peristent infection of WISH cell line with measles virus.
    Morzycka M; Szulc K; Wroczynska-Patkowa M
    Acta Microbiol Pol A; 1973; 5(3):241-3. PubMed ID: 4129369
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent measles virus infection in a calf kidney cell line. Note II. Study of some biological markers of the measles virus isolated from a selected chronically infected cell line.
    Sorodoc Y; Cernescu C; Cajal N
    Virologie; 1978; 29(2):141-7. PubMed ID: 676071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant measles AIK-C strain expressing current wild-type hemagglutinin protein.
    Kumada A; Komase K; Nakayama T
    Vaccine; 2004 Jan; 22(3-4):309-16. PubMed ID: 14670311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
    Brandler S; Tangy F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a persistent measles virus infection in HEp-2 cells.
    Rice JM; Wolff DA
    Microbios; 1978; 18(73-74):179-88. PubMed ID: 209291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passage in Vero cells alters the characteristics of measles AIK-C vaccine strain.
    Uejima H; Nakayama T; Komase K
    Vaccine; 2006 Feb; 24(7):931-6. PubMed ID: 16176848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal inactivation of different measles virus strains.
    Klamm H; Pollex G; Henning U
    Acta Virol; 1991 Apr; 35(2):200-2. PubMed ID: 1681719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype.
    Komase K; Nakayama T; Iijima M; Miki K; Kawanishi R; Uejima H
    Vaccine; 2006 Feb; 24(6):826-34. PubMed ID: 16140429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic study of the continuous RH cell line and its clones with a different susceptibility to measles virus.
    Gulevich NE; Nagieva FG
    Acta Virol; 1975 May; 19(3):204-8. PubMed ID: 239575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological characterisitcs of the pathological process in the central nervous system of monkeys infected with variants of measles virus strain L-16.
    Sharova OK; Rozina EE; Shteinberg LS; Gordienko NM; Kolyanova IS
    Acta Virol; 1979 Sep; 23(5):393-7. PubMed ID: 42298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines.
    Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P
    Dev Biol Stand; 1976 Dec 13-15; 37():297-300. PubMed ID: 1031692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles virus mutants and their implications in basic and applied virology.
    Makino S
    Ann Microbiol (Paris); 1977; 128B(4):507-15. PubMed ID: 565182
    [No Abstract]   [Full Text] [Related]  

  • 20. Obtaining of measles virus haemagglutinin from strain L-16 grown in primary cell cultures.
    Dorofeyeva LV
    Acta Virol; 1975 Nov; 19(6):497. PubMed ID: 1998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.